Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about VRTX
Recent news which mentions VRTX
< Previous
1
2
...
22
23
24
25
26
27
28
29
30
...
32
33
Next >
3 Monster Stocks to Buy Without Any Hesitation
August 18, 2023
Tickers
AMZN
MA
VRTX
Tags
AMZN
VRTX
Recent Press Releases
From
Motley Fool
2 Excellent Stocks to Buy and Hold Forever
August 17, 2023
Tickers
NVS
VRTX
Tags
NVS
Recent Press Releases
Market News
From
Motley Fool
The 3 Most Undervalued Biotech Stocks to Buy Now: August 2023
August 17, 2023
Tickers
AMGN
BNTX
IBB
PFE
Tags
NASDAQ:BNTX,NYSE:PFE,NASDAQ:UTHR,NASDAQ:IBB,NASDAQ;VRTX,NASDAQ:AMGN
PFE
UTHR
From
InvestorPlace
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 10 Years
August 14, 2023
Tickers
VRTX
Tags
Earnings
BZI/POD
Dividends
From
Benzinga
Missed Out on CRISPR Therapeutics? My Best Biotech Stock to Buy and Hold
August 14, 2023
Tickers
CRSP
VRTX
Tags
CRSP
Market News
Recent Press Releases
From
Motley Fool
Want to Get Richer? Buy and Hold These 5 Unstoppable Stocks
August 13, 2023
Tickers
AMZN
BEP
BEPC
GOOG
Tags
MELI
Recent Press Releases
GOOGL
From
Motley Fool
Could Vertex Pharmaceuticals Stock Help You Become a Millionaire?
August 10, 2023
Tickers
VRTX
Tags
Market News
Recent Press Releases
VRTX
From
Motley Fool
3 Explosive Stocks to Buy Right Now
August 10, 2023
Tickers
AXSM
USB
VRTX
Tags
VRTX
USB
AXSM
From
Motley Fool
3 Top Biotech Stocks Defying the Bear Market
August 10, 2023
Tickers
ALKS
REGN
VRTX
Tags
ALKS
VRTX
REGN
From
Motley Fool
2 Supercharged Growth Stocks That Could Make You Richer
August 09, 2023
Tickers
CRSP
EXAS
VRTX
Tags
VRTX
Recent Press Releases
Market News
From
Motley Fool
Is Vertex Pharmaceuticals Stock a Buy Now?
August 09, 2023
Tickers
VRTX
Tags
Recent Press Releases
Market News
VRTX
From
Motley Fool
Why CRISPR Therapeutics Stock Is Jumping Today
August 08, 2023
Tickers
CRSP
CS
VRTX
Tags
VRTX
Market News
CRSP
From
Motley Fool
Analyst Expectations for Vertex Pharmaceuticals's Future
August 07, 2023
Tickers
VRTX
Tags
BZI/AAR
VRTX
Market News
From
Benzinga
2 Top Biotech Stocks to Buy in August
August 06, 2023
Tickers
LLY
VRTX
Tags
Market News
Recent Press Releases
LLY
From
Motley Fool
3 Top Healthcare Stocks to Buy for August
August 05, 2023
Tickers
HUM
IDXX
VRTX
Tags
IDXX
HUM
VRTX
From
Motley Fool
3 Fantastic Growth Stocks to Buy in August
August 05, 2023
Tickers
AXSM
LLY
VRTX
Tags
Recent Press Releases
Market News
AXSM
From
Motley Fool
2 Nasdaq 100 Stocks That Are Surefire Buys in August and 1 to Avoid
August 04, 2023
Tickers
SIRI
TSLA
VRTX
Tags
Recent Press Releases
SIRI
Market News
From
Motley Fool
This Is Arguably the Single Best Stock to Buy Right Now
August 03, 2023
Tickers
VRTX
Tags
Recent Press Releases
Market News
VRTX
From
Motley Fool
Vertex Pharma Raises Annual Forecast On Strong Uptake For Cystic Fibrosis Drug, Analysts Says Investors' Focus On Non-CF Pipeline
August 02, 2023
Tickers
CRSP
VRTX
Tags
Expert Ideas
VRTX
Market News
From
Benzinga
Vertex Pharmaceuticals (VRTX) Q2 2023 Earnings Call Transcript
August 01, 2023
Tickers
VRTX
Tags
VRTX
Market News
Recent Press Releases
From
Motley Fool
Peering Into Vertex Pharmaceuticals's Recent Short Interest
August 01, 2023
Tickers
VRTX
Tags
Short Sellers
Market News
BZI/SHORTHIST
From
Benzinga
Nasdaq, S&P 500 Futures Pullback After Strong July; Why This Analyst Recommends Staying Fully Invested
August 01, 2023
Tickers
AMD
ANET
CAT
EA
Tags
SBUX
ANET
Trading Ideas
From
Benzinga
Rising Stars, Falling Trends: July's Industry ETF Winners And Losers
July 31, 2023
Tickers
AAL
ADM
AMGN
AMT
Tags
etf ranking
SPY
OIH
From
Benzinga
These 2 Stocks Are Heading for a Big Moment. Time to Buy?
July 31, 2023
Tickers
CRSP
VRTX
Tags
VRTX
Recent Press Releases
CRSP
From
Motley Fool
3 Biotech Stocks to Buy Before the Breakout
July 28, 2023
Tickers
ARCT
KRYS
TECH
VRTX
Tags
Market News
Stocks to Buy
ARCT
From
InvestorPlace
Could Vertex Pharmaceuticals Stock Help You Retire a Millionaire?
July 27, 2023
Tickers
VRTX
Tags
VRTX
Recent Press Releases
Market News
From
Motley Fool
3 Biotech Stocks You Better Be Buying on Each and Every Dip
July 27, 2023
Tickers
GMAB
JNJ
NVO
NVS
Tags
NVS
GMAB
NYSE:NVO,NASDAQ:VRTX,NASDAQ:GMAB,NYSE:JNJ,NYSE:NVS
From
InvestorPlace
If You Can Only Buy One Biotech Stock, It Better Be One of These 3 Names
July 26, 2023
Tickers
REGN
UTHR
VRTX
Tags
UTHR
VRTX
REGN
From
InvestorPlace
2 No-Brainer Cathie Wood Stocks to Buy Right Now
July 26, 2023
Tickers
ARKG
ARKK
PFE
VRTX
Tags
Market News
Recent Press Releases
ARKK
From
Motley Fool
A Look Into Vertex Pharmaceuticals Inc's Price Over Earnings
July 25, 2023
Tickers
VRTX
Tags
Intraday Update
BZI/PE
Benzinga
From
Benzinga
< Previous
1
2
...
22
23
24
25
26
27
28
29
30
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.